Melanoma

Recent published results

• What the CheckMate 401 Trial Found — Nivolumab + Ipilimumab Across Diverse Melanoma Patients
• What Researchers Found Combining an IDO/PD-L1 Vaccine With Nivolumab in Melanoma
• What the COLUMBUS Trial Found — Encorafenib + Binimetinib for BRAF-Mutant Melanoma